Correction: Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs.

Correction: Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs.

Show other versions (1)

Bibliographic Details
Main Authors:	Min Shen, Yaqin Zhang, Nakhle Saba, Christopher P. Austin, Adrian Wiestner, Douglas S. Auld
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3815351

Similar Items

Correction: Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs
by: Min Shen, et al.
Published: (2013-01-01)

Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs.
by: Min Shen, et al.
Published: (2013-01-01)

Recent therapeutic advances in chronic lymphocytic leukemia [version 1; referees: 2 approved]
by: Prithviraj Bose, et al.
Published: (2017-10-01)

Therapeutic Targets in Chronic Lymphocytic Leukemia
by: Luca Laurenti, et al.
Published: (2020-11-01)

Therapeutic advancement of chronic lymphocytic leukemia
by: Lu Kang, et al.
Published: (2012-09-01)

Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
by: Hoeksema KA, et al.
Published: (2011-09-01)

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
by: Paolo Sportoletti, et al.
Published: (2021-06-01)

Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia.
by: Assieh Saadatpour, et al.
Published: (2011-11-01)

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
by: Sharad Khurana, et al.
Published: (2019-01-01)

Prognosis and new therapeutic approaches in chronic lymphocytic leukemia treatment
by: Otašević Vladimir, et al.
Published: (2019-01-01)

Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.
by: John Xie, et al.
Published: (2021-01-01)

Recent drug approvals for acute myeloid leukemia
by: Catherine Lai, et al.
Published: (2019-09-01)

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
by: Valentina Griggio, et al.
Published: (2020-11-01)

CD200: A Novel Therapeutic Target for Chronic Lymphocytic Leukemia
by: Wong, Karrie
Published: (2012)

CD200: A Novel Therapeutic Target for Chronic Lymphocytic Leukemia
by: Wong, Karrie
Published: (2012)

Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
by: Subir Roy Chowdhury, et al.
Published: (2018-01-01)

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Tadeusz Robak
Published: (2010-05-01)

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Tadeusz Robak
Published: (2010-05-01)

Targeting myeloid cells as a potential Chronic Lymphocytic Leukemia therapeutic strategy
by: Merchand Reyes, Giovanna
Published: (2020)

Chronic Lymphocytic Leukemia
by: Tiziana Vaisitti, et al.
Published: (2020-09-01)

Chronic Lymphocytic Leukemia
Published: (2012)

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
by: Dan A. Landau, et al.
Published: (2017-12-01)

Chronic lymphocytic leukemia/small lymphocytic lymphoma
by: E. A. Nikitin, et al.
Published: (2020-11-01)

Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review
by: Stefaniuk P, et al.
Published: (2021-02-01)

Economic evaluation of therapeutic sequences in the treatment of patients with chronic lymphocytic leukemia and coexisting conditions
by: Antonio Cuneo, et al.
Published: (2017-10-01)

Targeting Protein Phosphatase 2a as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
by: Liu, Qing
Published: (2008)

Developing Methods and Targeted Therapeutics to Address Complications of Ibrutinib Treatment in Chronic Lymphocytic Leukemia
by: Hu, Eileen Yifan
Published: (2020)

In Vitro Drug Sensitivity and Apoptosis in Chronic Lymphocytic Leukemia
by: Norberg, Maria
Published: (2010)

Federal Library Legislation Update
by: Skip Auld
Published: (2000-10-01)

Federal Library Legislation Update
by: Skip Auld
Published: (2000-08-01)

Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01)

Immunogenetics of chronic lymphocytic leukemia
by: Nikhil Patkar, et al.
Published: (2017-01-01)

Chronic lymphocytic leukemia in China
by: Gale, R.P
Published: (2022)

Lenalidomide and Chronic Lymphocytic Leukemia
by: Ana Pilar González-Rodríguez, et al.
Published: (2013-01-01)

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
by: Celso Arrais Rodrigues, et al.

GPI-Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
by: Lia Farahi, et al.
Published: (2019-06-01)

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia
by: Berthou Christian, et al.
Published: (2010-12-01)

Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
by: Muhammad Haseeb, et al.
Published: (2018-11-01)

Characterization of DNA replication control mechanisms involved in evolution and therapeutic resistance of chronic lymphocytic leukemia
by: Grgurevic, Srdana
Published: (2016)

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
by: Lu Lichun, et al.
Published: (2007-05-01)